Literature DB >> 20096725

Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro.

V Dehousse1, N Garbacki, S Jaspart, D Castagne, G Piel, A Colige, B Evrard.   

Abstract

Chitosan and trimethylchitosan (TMC)-siRNA nanoparticles were produced by simple complexation technique or by ionic gelation using tripolyphosphate (TPP). The obtained complexes were characterized in terms of physicochemical properties such as size, zeta potential, complexation efficiency and stability. Furthermore, cytotoxicity, cell uptake and transfection efficiency of polyplexes were evaluated in vitro. Under pH condition of cell culture medium, a strong decrease in siRNA condensation efficiency was observed with chitosan nanoparticles. This characteristic resulted in low transfection efficiencies in HEK293 cell line. Formulation of chitosan polyplexes with TPP led to improvement of polyplexes stability but no significant increase in transfection efficiency was observed compared to simple chitosan complexes. By contrast, TMC complexes did not have pH dependency on siRNA complexation. TMC-siRNA nanoparticles were stable in physiological condition. Accordingly, cellular uptake was increased compared to chitosan polyplexes. However, improvement of transfection efficiency was low regarding to cellular uptake of these complexes. Chitosan and TMC complexes present some characteristics favourable for siRNA delivery, such as ability to integrate siRNA into small discrete particles or low toxicity of the complexes. This study also highlights the importance of complexes stability in physiological environment for siRNA transfection purposes. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096725     DOI: 10.1016/j.ijbiomac.2010.01.010

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Evaluation of Chitosan-Tripolyphosphate Nanoparticles as a p-shRNA Delivery Vector: Formulation, Optimization and Cellular Uptake Study.

Authors:  Mahdi Karimi; Pinar Avci; Mohsen Ahi; Tarane Gazori; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopharm Drug Deliv       Date:  2013-09-01

2.  Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.

Authors:  Bo Xiao; Panpan Ma; Lijun Ma; Qiubing Chen; Xiaoying Si; Lewins Walter; Didier Merlin
Journal:  J Colloid Interface Sci       Date:  2016-11-26       Impact factor: 8.128

3.  Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.

Authors:  Mohammed Jafar; Mohammed Saifuddin Khalid; Hajer Alghamdi; Mohd Amir; Sarah Aon Al Makki; Ohud Saud Alotaibi; Afnan Ali Al Rmais; Syed Sarim Imam; Sultan Alshehri; Sadaf Jamal Gilani
Journal:  AAPS PharmSciTech       Date:  2022-02-10       Impact factor: 3.246

4.  Ternary polymeric nanoparticles for oral siRNA delivery.

Authors:  Jing Zhang; Chunbai He; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

5.  Antifungal activity of chitosan nanoparticles and correlation with their physical properties.

Authors:  Ling Yien Ing; Noraziah Mohamad Zin; Atif Sarwar; Haliza Katas
Journal:  Int J Biomater       Date:  2012-07-08

Review 6.  RNA interference-based nanosystems for inflammatory bowel disease therapy.

Authors:  Jian Guo; Xiaojing Jiang; Shuangying Gui
Journal:  Int J Nanomedicine       Date:  2016-10-12

Review 7.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.